blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2013366

EP2013366 - Sequencing of the L10 codon of the HIV gag gene [Right-click to bookmark this link]
Former [2009/03]NOVEL OLIGONUCLEOTIDE PRIMERS AND METHODS FOR DNA REPLICATION
[2016/27]
StatusNo opposition filed within time limit
Status updated on  06.10.2017
Database last updated on 14.06.2024
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): IS		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Siemens Healthcare Diagnostics Inc.
511 Benedict Avenue
Tarrytown, NY 10591 / US
[2016/48]
Former [2009/03]For all designated states
Siemens Healthcare Diagnostics Inc.
511 Benedict Avenue
Tarrytown, NY 10591 / US
Inventor(s)01 / REYNOLDS, Rebecca
167 Highland St.
Milford, MA 01757 / US
 [2009/03]
Representative(s)Schweitzer, Klaus, et al
Plate Schweitzer Zounek Industriepark Kalle-Albert Rheingaustrasse 196
65203 Wiesbaden / DE
[2014/41]
Former [2009/03]Maier, Daniel Oliver
Siemens AG Postfach 22 16 34
80506 München / DE
Application number, filing date07797310.501.05.2007
[2009/03]
WO2007US67920
Priority number, dateUS20060746124P01.05.2006         Original published format: US 746124 P
[2009/03]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007130967
Date:15.11.2007
Language:EN
[2007/46]
Type: A2 Application without search report 
No.:EP2013366
Date:14.01.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 15.11.2007 takes the place of the publication of the European patent application.
[2009/03]
Type: B1 Patent specification 
No.:EP2013366
Date:30.11.2016
Language:EN
[2016/48]
Search report(s)International search report - published on:US02.04.2009
(Supplementary) European search report - dispatched on:EP02.11.2009
ClassificationIPC:C12Q1/68
[2009/03]
CPC:
C12Q1/6867 (EP,US); C12Q1/6869 (EP,US)
C-Set:
C12Q1/6867, C12Q2525/204, C12Q2525/161, C12Q2525/155 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/48]
Former [2009/03]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Sequenzierung vom L10-Codon vom HIV-gag-Gen[2016/28]
English:Sequencing of the L10 codon of the HIV gag gene[2016/27]
French:Séquençage du codon L10 du gène gag du VIH[2016/28]
Former [2009/03]NEUE OLIGONUKLEOTIDPRIMER UND VERFAHREN ZUR DNA-REPLIKATION
Former [2009/03]NOVEL OLIGONUCLEOTIDE PRIMERS AND METHODS FOR DNA REPLICATION
Former [2009/03]NOUVELLES AMORCES OLIGONUCLÉOTIDES ET PROCÉDÉ DE RÉPLICATION D'ADN
Entry into regional phase08.09.2008National basic fee paid 
08.09.2008Search fee paid 
08.09.2008Designation fee(s) paid 
08.09.2008Examination fee paid 
Examination procedure08.09.2008Examination requested  [2009/03]
13.05.2009Amendment by applicant (claims and/or description)
10.02.2010Despatch of a communication from the examining division (Time limit: M06)
18.08.2010Reply to a communication from the examining division
15.12.2010Despatch of a communication from the examining division (Time limit: M08)
09.12.2011Reply to a communication from the examining division
17.12.2012Despatch of a communication from the examining division (Time limit: M06)
05.08.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
08.10.2013Reply to a communication from the examining division
16.04.2015Despatch of a communication from the examining division (Time limit: M04)
26.08.2015Reply to a communication from the examining division
16.03.2016Despatch of a communication from the examining division (Time limit: M02)
23.05.2016Reply to a communication from the examining division
17.06.2016Communication of intention to grant the patent
17.10.2016Fee for grant paid
17.10.2016Fee for publishing/printing paid
17.10.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.02.2010
Opposition(s)31.08.2017No opposition filed within time limit [2017/45]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
08.10.2013Request for further processing filed
08.10.2013Full payment received (date of receipt of payment)
Request granted
11.12.2013Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
09.12.2011Request for further processing filed
09.12.2011Full payment received (date of receipt of payment)
Request granted
22.12.2011Decision despatched
Fees paidRenewal fee
18.05.2009Renewal fee patent year 03
21.05.2010Renewal fee patent year 04
20.05.2011Renewal fee patent year 05
18.05.2012Renewal fee patent year 06
21.05.2013Renewal fee patent year 07
19.05.2014Renewal fee patent year 08
13.05.2015Renewal fee patent year 09
20.05.2016Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.05.2007
AT30.11.2016
BE30.11.2016
CY30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
IT30.11.2016
LT30.11.2016
LV30.11.2016
MC30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SI30.11.2016
SK30.11.2016
TR30.11.2016
BG28.02.2017
GR01.03.2017
IS30.03.2017
PT30.03.2017
IE01.05.2017
LU01.05.2017
MT01.05.2017
CH31.05.2017
LI31.05.2017
[2020/33]
Former [2020/15]HU01.05.2007
AT30.11.2016
BE30.11.2016
CY30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
IT30.11.2016
LT30.11.2016
LV30.11.2016
MC30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SI30.11.2016
SK30.11.2016
TR30.11.2016
BG28.02.2017
GR01.03.2017
PT30.03.2017
IE01.05.2017
LU01.05.2017
MT01.05.2017
CH31.05.2017
LI31.05.2017
Former [2019/46]HU01.05.2007
AT30.11.2016
BE30.11.2016
CY30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
IT30.11.2016
LT30.11.2016
LV30.11.2016
MC30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SI30.11.2016
SK30.11.2016
BG28.02.2017
GR01.03.2017
PT30.03.2017
IE01.05.2017
LU01.05.2017
MT01.05.2017
CH31.05.2017
LI31.05.2017
Former [2019/31]HU01.05.2007
AT30.11.2016
BE30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
IT30.11.2016
LT30.11.2016
LV30.11.2016
MC30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SI30.11.2016
SK30.11.2016
BG28.02.2017
GR01.03.2017
PT30.03.2017
IE01.05.2017
LU01.05.2017
MT01.05.2017
CH31.05.2017
LI31.05.2017
Former [2018/43]AT30.11.2016
BE30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
IT30.11.2016
LT30.11.2016
LV30.11.2016
MC30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SI30.11.2016
SK30.11.2016
BG28.02.2017
GR01.03.2017
PT30.03.2017
IE01.05.2017
LU01.05.2017
MT01.05.2017
CH31.05.2017
LI31.05.2017
Former [2018/23]AT30.11.2016
BE30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
IT30.11.2016
LT30.11.2016
LV30.11.2016
MC30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SI30.11.2016
SK30.11.2016
BG28.02.2017
GR01.03.2017
PT30.03.2017
IE01.05.2017
LU01.05.2017
CH31.05.2017
LI31.05.2017
Former [2018/17]AT30.11.2016
BE30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
IT30.11.2016
LT30.11.2016
LV30.11.2016
MC30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SI30.11.2016
SK30.11.2016
BG28.02.2017
GR01.03.2017
PT30.03.2017
LU01.05.2017
CH31.05.2017
LI31.05.2017
Former [2018/13]AT30.11.2016
BE30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
IT30.11.2016
LT30.11.2016
LV30.11.2016
MC30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SI30.11.2016
SK30.11.2016
BG28.02.2017
GR01.03.2017
PT30.03.2017
CH31.05.2017
LI31.05.2017
LU31.05.2017
Former [2018/06]AT30.11.2016
BE30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
IT30.11.2016
LT30.11.2016
LV30.11.2016
MC30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SI30.11.2016
SK30.11.2016
BG28.02.2017
GR01.03.2017
PT30.03.2017
LU31.05.2017
Former [2017/52]AT30.11.2016
BE30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
IT30.11.2016
LT30.11.2016
LV30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SI30.11.2016
SK30.11.2016
BG28.02.2017
GR01.03.2017
PT30.03.2017
LU31.05.2017
Former [2017/38]AT30.11.2016
BE30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
IT30.11.2016
LT30.11.2016
LV30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SK30.11.2016
BG28.02.2017
GR01.03.2017
PT30.03.2017
LU31.05.2017
Former [2017/37]AT30.11.2016
BE30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
IT30.11.2016
LT30.11.2016
LV30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SK30.11.2016
GR01.03.2017
PT30.03.2017
LU31.05.2017
Former [2017/36]AT30.11.2016
BE30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
LT30.11.2016
LV30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
SK30.11.2016
GR01.03.2017
PT30.03.2017
LU31.05.2017
Former [2017/35]AT30.11.2016
CZ30.11.2016
DK30.11.2016
EE30.11.2016
ES30.11.2016
FI30.11.2016
LT30.11.2016
LV30.11.2016
NL30.11.2016
PL30.11.2016
RO30.11.2016
SE30.11.2016
GR01.03.2017
PT30.03.2017
Former [2017/31]AT30.11.2016
ES30.11.2016
FI30.11.2016
LT30.11.2016
LV30.11.2016
NL30.11.2016
PL30.11.2016
SE30.11.2016
GR01.03.2017
PT30.03.2017
Former [2017/26]AT30.11.2016
ES30.11.2016
FI30.11.2016
LT30.11.2016
LV30.11.2016
PL30.11.2016
SE30.11.2016
GR01.03.2017
PT30.03.2017
Former [2017/12]LV30.11.2016
Documents cited:Search[X]US2003219770  (ESHLEMAN JAMES R [US], et al) [X] 1-34 * figure 5 *;
 [X]US2002160361  (LOEHRLEIN CHRISTINE [US], et al) [X] 1-34 * paragraphs [0006] - [0010]; figures 1,2 *;
 [X]WO03025202  (ALEXION PHARMA INC [US], et al) [X] 1-34 * figures 1-3 *;
 [A]WO0198539  (HITACHI CHEMICAL CO LTD [JP], et al) [A] 1-34 * the whole document *
 [A]  - ROUDINSKII NIKITA I ET AL, "Diversity of human immunodeficiency virus type 1 subtype A and CRF03-AB protease in eastern Europe: Selection of the V77I variant and its rapid spread in injecting drug user populations", JOURNAL OF VIROLOGY, (200410), vol. 78, no. 20, ISSN 0022-538X, pages 11276 - 11287, XP002549418 [A] 1-34 * the whole document *

DOI:   http://dx.doi.org/10.1128/JVI.78.20.11276-11287.2004
International search[A]US2002028455  (LAIBINIS PAUL E [US], et al);
 [A]US5866336  (NAZARENKO IRINA A [US], et al)
 [A]  - WILTON ET AL., HUMAN MUTATION, (1998), vol. 11, pages 252 - 258, XP002094957

DOI:   http://dx.doi.org/10.1002/(SICI)1098-1004(1998)11:3<252::AID-HUMU11>3.0.CO;2-Y
Examination   - Robert W Shafer ET AL, "A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies", HIV sequence compendium, (20010101), pages 1 - 51, URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274565/pdf/nihms65128.pdf, XP055254236
by applicantUS2003219770
 US2002160361
 WO03025202
 EP0655506
    - SANGER ET AL., PNAS (USA, (1977), vol. 74, no. 12, pages 5463 - 5467
    - MCBRIDE ET AL., CLINICAL CHEMISTRY, (1989), vol. 35, pages 2196 - 2201
    - HUGGETT ET AL., GENES AND IMMUNITY, (2005), pages 1 - 6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.